Silo Pharma | 8-K: Current report
Silo Pharma | 8-K: Current report
Silo Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Weisblum Eric
Silo Pharma | 4: Statement of changes in beneficial ownership of securities-Officer Weisblum Eric
Silo Pharma | DEFR14A: Definitive proxy statement in connection with contested solicitations
Silo Pharma | SCHEDULE 13G: Others
Silo Pharma | 10-Q: Q3 2024 Earnings Report
Silo Pharma | DEFA14A: Others
Silo Pharma | 8-K: Current report
Silo Pharma | ARS: Annual Report to Security Holders
Silo Pharma | DEFA14A: Others
Silo Pharma | DEF 14A: Definitive information statements
Silo Pharma | 8-K: Current report
Silo Pharma | 424B3: Prospectus
Silo Pharma | EFFECT: Others
Silo Pharma | CORRESP: CORRESP
Silo Pharma | UPLOAD: Others
Silo Pharma | S-1: General form for registration of securities under the Securities Act of 1933
Silo Pharma | 10-Q: Q2 2024 Earnings Report
Silo Pharma | D: Filing D
Unlock the Full List